Sleep Cycle Prices Certainty, Not Board Rejection

Summary: SLEEP.SE closed at SEK 24.35 on May 22, 2026, just 0.6% below Altor's public cash offer of SEK 24.50. That looks almost riskless until you read the actual tender math. Altor has irrevocable undertakings for 62.9% of Sleep Cycle, but the independent board now recommends that shareholders do not accept the bid, and one 6.0% holder says its earlier SEK 35-45 fair-value range still stands. If that 6.0% stays out, Altor would need about 87% of the remaining shares to get to the 90% squeeze-out threshold. The stock still trades as if the cash outcome is the base case and the holdout risk is minor. That is the disagreement. [1][2][3]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	Sleep Cycle prices certainty, not board rejection	Europe / Nordics / public cash offer / holdout math	The stock closed at SEK 24.35 against a SEK 24.50 offer even after the independent board told holders not to tender on May 22, 2026. The long upside is capped at 0.6% absent a bump, but a break or sub-90% outcome can produce materially larger downside in the stock. [1][2][3]	Official offer announcement dated May 11, 2026; official board statement dated May 22, 2026; live quote checked on the May 22 close. [1][2][3]	Acceptance is expected to run from May 28 to June 22, with settlement around June 30. [1][2]	Best skew in the screen. If the offer closes unchanged, the stock has almost no room left. If the deal slips, the re-rating can be large.	Selected.
2	MKH trades below a RM2.00 mandatory offer path	Broader Asia / Malaysia / mandatory offer / control transaction	`MKH.MY` showed RM 1.91 on the quote page after Whitmore agreed to buy blocks at RM 2.00 and disclosed a conditional mandatory offer path at the same price. [4]	KLSE Screener announcement and quote page checked in this run. [4]	The offer path depends on the 18.1% conditional SSA becoming unconditional. [4]	Moderate. The gap exists, but only 4.7% gross at the checked quote.	Rejected because the mandatory offer is still conditional on the last block turning unconditional.
3	Ryomo Systems has a live TOB but almost no spread	Japan / local-market equity / parent-subsidiary clean-up	Ryomo Systems closed at JPY 5,180 on May 22, 2026 against a live tender price of JPY 5,200. [5][6]	Official TOB terms dated May 14, 2026; live quote checked at the May 22 Tokyo close. [5][6]	Tender runs through July 8, 2026. [6]	Low. Gross upside is only 0.4%.	Rejected because the spread is too thin for the timeline and execution risk.
4	Assertio is a cash deal with little spread left	U.S. / healthcare / cash tender	`ASRT.US` last printed $23.435 on a checked source timestamp of 2026-05-22 22:00:14, versus a $23.50 cash tender. [7][8]	SEC tender materials dated May 18, 2026; live quote checked in this run. [7][8]	Offer expires June 15, 2026. [8]	Low. Gross upside is about 0.3%.	Rejected because the tape already prices near-complete certainty.

Selected opportunity: Sleep Cycle (SLEEP.SE).

Why this one now: It is the cleanest case in the screen where the market still hugs the public cash price even after a fresh negative development. The board's rejection does not destroy the bid, but it does make the 90% squeeze-out path more demanding than the tape suggests.

What should surprise the reader: A stock can trade almost at cash while the actual acceptance math has become awkward. At SEK 24.35, the market acts as if the Altor outcome is effectively banked. The documents say otherwise.

Geographic Search Audit

U.S. candidate screened: Assertio (ASRT.US). Rejected because the spread to the cash tender is only about 0.3%. [7][8]
Japan candidate screened: Ryomo Systems (9691.T). Rejected because the spread to the live tender is only about 0.4%. [5][6]
Japan size / price filter result: The Japan lane first prioritized local small-cap and mid-cap names at or below JPY 800 per share. No name in that bucket surfaced in this run with a fresher hard-value mismatch than the higher-priced live tender situations, so the lane was escalated and still rejected on spread quality.
Broader Asia candidate screened: MKH Berhad (MKH.MY). Rejected because the RM 2.00 mandatory-offer path still depends on a conditional block purchase becoming unconditional. [4]
Europe / UK candidate screened: Sleep Cycle (SLEEP.SE). Selected. [1][2][3]

Why This Is the Best Opportunity Right Now

The easy version of this tape says there is no trade. Sleep Cycle closed at SEK 24.35. The public cash offer is SEK 24.50. That is a gap of only SEK 0.15, or about 0.6%. [1][3]

That is precisely why it matters.

If a deal closes unchanged, the upside for a long is basically gone. The market already knows the number. What it may still underprice is the cost of getting from 62.9% locked support to 90% control, now that the independent board has recommended that holders not tender. [1][2]

Fact: Snark BidCo's offer is SEK 24.50 in cash per share. [1]

Fact: the offeror has irrevocable undertakings representing about 62.9% of the shares and votes. [1][2]

Fact: the independent board said on May 22, 2026 that shareholders should not accept the offer, and cited both current growth investments and a run-off value that it believes is at or above the offer. [2]

Fact: the board also pointed to a statement from shareholder Returnado AB, which holds about 6.0% of the shares, saying its previously published fair-value range of SEK 35-45 remains unchanged. [2]

Inference: if that 6.0% holder remains out, Altor must source roughly 27.1% more shares from only 31.1% of the register, or about 87.1% of what remains, to reach 90% and force a squeeze-out. That is a much tighter path than the current tape implies. [1][2]

This is why Sleep Cycle is the best screen today. The payoff is no longer about chasing a cash spread. It is about asking whether the stock should really trade almost at cash after the board has publicly made the holdout case stronger.

What Should Surprise the Reader

The surprise is not that Altor made a bid. The surprise is that the stock still trades almost as if the board never objected.

The board did more than complain about price. It handed minority holders a live public argument for not tendering. It also surfaced a 6.0% shareholder whose disclosed valuation range remains far above the bid. [2]

The tape barely moved.

That is unusual. If the board's rejection is irrelevant, then the market is right and the deal is effectively done. If the rejection matters at the margin, then a stock trading 0.6% below cash is too complacent.

The Setup

Altor's vehicle, Snark BidCo AB, announced a public cash offer of SEK 24.50 per share for Sleep Cycle on May 11, 2026. The offer value is about SEK 497 million. The offeror said it had already secured irrevocable undertakings from holders representing about 62.9% of the shares and votes. [1]

The offer conditions matter.

The bid is conditional on, among other things, the offer being accepted to the extent that the offeror becomes owner of more than 90% of the shares, plus customary approvals including foreign direct investment approval. The offeror explicitly reserves the right to waive the 90% condition and complete the bid at a lower acceptance level. [1]

That waiver right is the core wrinkle. It means failure is not binary.

If Altor reaches 90%, Sleep Cycle is on a standard squeeze-out path and the stock should collapse into the cash consideration.

If Altor waives the condition and closes with a lower level of support, the stock can stop being a pure cash-arb instrument. A minority stub under a controlling owner does not have to trade at SEK 24.50.

Then the board raised the temperature.

On May 22, 2026, the independent board recommended that holders not accept the offer. The statement is unusually direct. The board says the offer does not adequately reflect the company's value, cites its subscription cash generation and growth investments, and says that even a run-off scenario with scaled-back investment would be worth in line with or above the offer. [2]

You do not have to believe the full SEK 35-45 story to see the problem. The point is narrower. The board has publicly armed holdouts, and the market still prices almost perfect cash certainty.

The Market Price

Market Level	Current Reading	Source / Timestamp	Why It Matters
`SLEEP.SE` close	SEK 24.35	Nasdaq Stockholm close on May 22, 2026; checked via MarketScreener and Investing in this run. [3]	Current entry reference.
Public cash offer	SEK 24.50	Snark BidCo offer announcement, May 11, 2026. [1]	Hard public bid price.
Gap to cash offer	-0.6%	Author calculation from [1][3]	Shows how little upside remains for a long if the offer closes unchanged.
Pre-offer close	SEK 16.66	Investing historical data for May 8, 2026. [3]	A useful reference for what the market thought before the bid.
Offer value	SEK 497m	Offer announcement. [1]	Sizes the transaction.
Irrevocable undertakings	62.9%	Offer announcement and board statement. [1][2]	Defines the locked support base.
Additional vocal holder	6.0%	Board statement. [2]	Increases the difficulty of reaching 90% if it stays out.
Shares still needed to reach 90%	27.1%	Author calculation from [1][2]	Raw gap from current locked support.
Required take-up from uncommitted register	73.0%	Author calculation from [1]	What Altor needs from the remaining 37.1% if no other holder is excluded.
Required take-up if the 6.0% holder stays out	87.1%	Author calculation from [1][2]	The cleanest expression of the holdout-risk math.
Acceptance period	Around May 28 to June 22, 2026	Offer announcement and board statement. [1][2]	Near-dated catalyst window.
Expected settlement start	Around June 30, 2026	Offer announcement and board statement. [1][2]	Defines the first hard closing clock.

The Positioning

I did not verify live borrow cost, securities-lending availability, short interest, or listed option-chain quality for Sleep Cycle in this run.

That missing data matters because the cleanest expression here is bearish.

Still, the tape gives a usable positioning signal.

On May 11, after the bid, the stock jumped from SEK 16.66 to SEK 24.30 on 871.49K volume. By May 22, it was still sitting at SEK 24.35, with daily volume down to 95.85K. [3]

Inference: the market has already done the first-step arb trade. The current holder base is likely more event-driven, more anchored to the cash consideration, and less interested in underwriting the holdout path.

That is what makes the board statement matter. It arrived after the easy repricing. If the marginal holder now treats SEK 24.50 as the default outcome, the downside from any wobble in that assumption is asymmetric.

Missing-data note: borrow and option-liquidity conditions were not safely verified in this run. Any live short expression must check them first.

The Catalyst

This setup has a real clock and not much room for narrative drift.

Offer opens around May 28. That is when actual tender behavior begins. [1][2]
Offer runs to around June 22. Shareholders have a defined window to decide whether the board is right or the cash is good enough. [1][2]
Settlement starts around June 30. If Altor waives conditions or reaches a high enough acceptance level, the tape should reflect that quickly. [1][2]
Any update on acceptances or conditions matters. The key observable is whether the path to 90% looks real or whether the deal shifts into a lower-acceptance, lower-certainty structure.

The catalyst is not a macro opinion. It is a document-driven process with dates.

The Gap

The market appears to be pricing one of two optimistic stories:

the board rejection will not matter, because enough holders will tender anyway, or
even if 90% is hard to reach, Altor can waive and the stock will still remain near SEK 24.50.

The first story looks too easy.

The irrevocables get Altor to 62.9%. That is a long way from 90%. Even without assuming the 6.0% holder stays out, Altor still needs roughly 73% of the uncommitted register. If that 6.0% bloc really does not like the price, the hurdle rises to about 87% of what remains. [1][2]

The second story ignores what a waived condition means.

Inference: if the offer closes below 90%, the cash bid stops being a full-certainty takeout for all holders. At that point the stock can trade on minority-stub logic, not on merger-arb logic. There is no reason that outcome must hold the stock at SEK 24.50.

That is the disagreement.

The market prices certainty. The documents price friction.

The Payoff Map

The cleanest expression is short Sleep Cycle common stock, but only if live borrow is available and the borrow fee is acceptable.

This is not an options-first setup. I did not verify a live listed option chain with enough liquidity and spread quality to recommend an options structure responsibly.

The payoff is attractive because the long side is already saturated by the tape.

If the bid closes unchanged at SEK 24.50, the short loses only about 0.6% from the checked close.
If a rival or Altor itself raises meaningfully above the current terms, the short loses more, but that requires a new public event.
If the board rejection actually matters and the offer path loses certainty, the stock can move far more than 0.15 kronor away from cash.

This is one of the few screens where the market leaves almost no upside for the wrong side of the trade.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	20%	SEK 27.00	+10.9% underlying, -10.9% for a short	1 to 6 weeks	A competing bidder emerges above the 10% threshold that can release locked holders, or Altor raises materially to defend the deal.	Medium
Base Case	50%	SEK 24.50	+0.6% underlying, -0.6% for a short	1 to 5 weeks	Altor closes at current terms, or waives conditions without forcing an immediate repricing.	Medium
Bottom Case	30%	SEK 17.50	-28.1% underlying, +28.1% for a short	2 to 8 weeks	Holdouts make the 90% path too hard, the bid loses certainty, or the stock reanchors toward pre-bid trading levels rather than cash certainty.	Medium
Invalidation / Stop Condition	n/a	Sustained trade above SEK 25.50 on credible evidence of a sweetened bid or a materially stronger acceptance path	n/a	Immediate once visible	The thesis fails when the market gets new evidence that the current bid is not the true ceiling.	Medium

Probability-weighted expected value: about SEK 22.90 for the underlying, or roughly -5.9% from the checked close. For a short entered near SEK 24.35, that implies an expected gain of roughly +5.9% before borrow cost and execution friction.

Current market price / level: SLEEP.SE SEK 24.35. [3]

Timestamp: Nasdaq Stockholm close on May 22, 2026, checked on May 23, 2026 Singapore time. [3]

Primary instrument: Sleep Cycle AB common stock.

Alternative expressions considered: waiting for the acceptance-period data; options. Waiting was rejected because the mispricing is precisely the market's current certainty assumption. Options were rejected because live strike depth, bid-ask spreads, and open interest were not safely verified in this run.

Confidence: Medium-Low. The documentary case is strong. The live-borrow and options data are not.

What Could Go Wrong

The strongest counterargument is simple: the board can complain, but 62.9% is already locked and Altor can waive the 90% condition. [1][2]

That is a serious argument. It may be enough.

Three more risks matter:

A sweetened bid can hurt a short fast. The irrevocable undertakings can be released if a competing offer tops the consideration by more than 10% and Snark BidCo does not match it within ten business days. [1] That creates real headline risk above the current ceiling.
The board may be right on value, not just process. It points to early medical traction, regulatory work, and 42% year-on-year B2B revenue growth in Q1. [2] If the market begins to believe that story, the stock can hold up even without clean squeeze-out certainty.
Borrow can ruin the expression. A good thesis with bad stock-loan terms is not a good trade. I did not verify borrow cost or locate certainty in this run.

What Would Prove This Wrong

This thesis weakens materially if one of the following happens:

Altor or a rival publishes a clearly superior bid and the market holds above SEK 25.50 on that new evidence.
Acceptance updates or shareholder disclosures show a much easier path to 90% than the current register math implies.
Borrow becomes unavailable or uneconomic, making the cleanest expression impossible.
The stock trades at or above the current offer on new evidence that the board's rejection is not affecting tender behavior at all.

Bottom Line

Sleep Cycle is not mispriced because the market missed the bid. The market saw the bid immediately.

It may be mispriced because it refuses to downgrade certainty after the board told holders not to tender.

At SEK 24.35, the long side has almost no room left if the current bid closes unchanged. The short side has to respect sweetened-bid risk, but the underlying payoff is still skewed because a broken or sub-90% path can reprice much more violently than the remaining SEK 0.15 spread suggests.

Best trade strategy: Short Sleep Cycle common stock, borrow permitting. This is not an options-first setup.

Research Quality Scorecard

Criterion	Score	Evidence Note
Market disagreement	5	The note isolates a clear mismatch between a stock trading 0.6% below cash and a fresh board recommendation not to tender.
Evidence base	4	Core claims rely on the official offer announcement, the official board statement, and live checked market-price pages. Borrow and options data were not verified.
Positioning and flows	4	The post-bid tape, the fall in daily volume, the locked 62.9% block, and the public 6.0% holdout signal support the positioning read, but stock-loan data is missing.
Catalyst path	5	The acceptance period and expected settlement dates are explicit and near-dated.
Payoff architecture	5	A short loses only about 0.6% if the existing bid closes unchanged, but can gain materially if certainty breaks.
Invalidation discipline	4	The note defines observable invalidation around a credible sweetened bid, a clearly easier path to 90%, or bad borrow terms.
Differentiated insight	5	The key insight is the tender-math friction: 73.0% of the uncommitted register is needed for 90%, and 87.1% if the 6.0% holder stays out.
Client value	5	The piece teaches readers how to think about cash-certainty trades, holdout math, and waived tender conditions even if they never short the stock.

Total Score: 37 / 40

Verdict: Publish

AI Illustration Prompt

A realistic, high-value, high-end editorial cover image for The Mispricing Desk about Sleep Cycle in May 2026. Show a refined Scandinavian bedroom at blue hour, minimal and expensive, with a glowing digital bedside display frozen at SEK 24.35. Above the bed, suspend a transparent cash-offer card reading SEK 24.50 that looks almost within reach but is visibly cracked by a thin fault line. On one side of the room, place neatly stacked tender documents stamped 62.9% irrevocable; on the other, a single defiant card reading 6.0% holdout with a handwritten fair-value range 35-45. In the background, include a subtle wall calendar with the dates 28 May, 22 June, and 30 June circled in red pencil. Mood: quiet, forensic, tense, premium, Nordic, institutional. Palette: cool steel blue, soft slate, pale oak, white paper, and one restrained red accent. No cartoon charts, no traders shouting, no generic finance imagery. Make it feel like a Bloomberg Markets or Economist feature cover. Include a subtle but clear watermark or text treatment reading The Mispricing Desk.

Sources

[1] Snark BidCo AB announces a cash offer of SEK 24.50 per share to the shareholders of Sleep Cycle AB (publ), published May 11, 2026

[2] Sleep Cycle board statement recommending shareholders not accept Altor's public cash offer, published May 22, 2026

[3] Sleep Cycle price pages checked in this run: MarketScreener quote page and Investing historical data for May 22, 2026 close and Investing historical data

[4] MKH Berhad announcement and quote page showing RM2.00 offer path and RM1.91 checked quote

[5] Ryomo Systems quote page, checked at the May 22, 2026 Tokyo close

[6] Mitsuba / Chubu Electric Power tender offer for Ryomo Systems, published May 14, 2026

[7] Stooq quote feed for ASRT.US, checked in this run

[8] Assertio tender-offer materials, SEC filing, filed May 18, 2026